Higher quality colonoscopies reduce colorectal cancer incidence, mortality
the ONA take:
According to a new study published in JAMA, researchers have found that higher adenoma detection rates from colonoscopy screenings may be associated with a lower lifetime colorectal cancer incidence and mortality without increased overall costs.
For the study, researchers sought to estimate the lifetime benefits, complications, and costs of an initial screening program at different levels of adenoma detection by analyzing data from the Kaiser Permanente health care system.
Results showed that among unscreened patients, the lifetime colorectal cancer risk was 34.2% per 1,000 and the lifetime colorectal cancer mortality risk was 13.4% per 1,000. Among those with the highest rates of adenoma detection, the lifetime colorectal cancer risk was 12.5% per 1,000.
In addition, researchers found that despite a higher number of colonoscopies and potential complications, there was no increase in overall costs due to the avoidance of cancer treatment costs.
Higher adenoma detection rates from colonoscopy screenings may be associated with a lower lifetime colorectal cancer incidence.
Sign Up for Free e-newsletters
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- A Witness to Letting Go: Nursing Care at the End of Life
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Modified XELIRI Noninferior to FOLFIRI for OS in Metastatic Colorectal Cancer
- Nabilone Improves Cancer-Associated Anorexia in Lung Cancer
- Direct-to-Consumer Genetic Test for Select BRCA Mutations Gets FDA Nod
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|